Oncologists Accepting Molina Healthcare in Boston, MAPage 5
135 verified oncologists in Boston, Massachusetts accept Molina Healthcare. Profiles cover focus areas including Surgical Oncology, Hematology & Oncology, and Medical Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Brigham and Women's Faulkner Hospital.
Michael Cassidy, M.D.
Oncology
Inhye Ahn, M.D.
Associate Director of the Chronic Lymphocytic Leukemia (CLL) Center, Senior Physician, Assistant Professor of Medicine at Harvard Medical School
Oncology
Clifton Mo, M.D.
Assistant Professor of Medicine
Oncology
Thanh Barbie, MD
Assistant Professor of Surgery, Harvard Medical School
Oncology
Marios Giannakis, MD
Associate Professor of Medicine, Harvard Medical School
Oncology
Candace Haddox, M.D.
Clinical Investigator, Sarcoma Center
Oncology
Mahasweta Gooptu, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Andrew Aguirre, MD, PHD
Associate Professor of Medicine, Harvard Medical School
Oncology
Tara Berman, M.D.
Medical Oncologist, Dana-Farber Cancer Institute; Faculty Member, Harvard Medical School
Oncology
Zofia Piotrowska, MD
Associate Professor of Medicine, Harvard Medical School
Oncology
Charlene Mantia, M.D.
Instructor in Medicine, Harvard Medical School
Oncology
Othon Iliopoulos, MD
Oncology
Martha Wadleigh, MD
Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School
Oncology
Otto Metzger, M.D.
Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School
Oncology
Rochelle Scheib, MD
Professor of Medicine, Harvard Medical School
Oncology
Matthew Oser, M.D./PH.D.
Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School where he runs a research laboratory focused on small cell lung cancer and is a; Associate Professor of Medicine, Harvard Medical School
Oncology
Rizwan Haq, MD, PHD
Assistant Professor, Harvard Medical School
Oncology
Shayna Sarosiek, MD
Senior Physician; Assistant Professor of Medicine, Harvard Medical School
Oncology
Ting Bao, M.D.
Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria
Oncology
David Jackman, M.D.
Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician
Oncology